G Medical Innovations Holdings Ltd (GMVD) Income Statement Analysis

See more : FACC AG (FACC.VI) Income Statement Analysis – Financial Results

Complete financial analysis of G Medical Innovations Holdings Ltd (GMVD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of G Medical Innovations Holdings Ltd, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.

You may be interested

Postal Savings Bank of China Co., Ltd. (1658.HK) Income Statement Analysis – Financial Results
Vodacom Group Limited (VOD.JO) Income Statement Analysis – Financial Results
Valeura Energy Inc. (PNWRF) Income Statement Analysis – Financial Results
The Middleby Corporation (MIDD) Income Statement Analysis – Financial Results
Nanya Technology Corporation (2408.TW) Income Statement Analysis – Financial Results

G Medical Innovations Holdings Ltd (GMVD)

Industry: Medical - Instruments & Supplies

Sector: Healthcare

Website: https://gmedinnovations.com

About G Medical Innovations Holdings Ltd

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

Metric	2022	2021	2020	2019	2018	2017	2016
Revenue	4.42M	5.06M	4.90M	5.53M	3.06M	109.00K	0.00
Cost of Revenue	3.64M	3.56M	4.23M	5.75M	4.03M	1.16M	0.00
Gross Profit	784.00K	1.50M	667.00K	-223.00K	-969.00K	-1.05M	0.00
Gross Profit Ratio	17.74%	29.70%	13.61%	-4.04%	-31.65%	-959.63%	0.00%
Research & Development	2.29M	1.68M	1.32M	2.55M	243.00K	186.00K	0.00
General & Administrative	24.86M	9.01M	7.66M	10.00M	12.61M	24.01M	0.00
Selling & Marketing	0.00	0.00	0.00	3.46M	664.00K	356.00K	0.00
SG&A	24.86M	9.01M	7.66M	10.00M	13.27M	24.36M	0.00
Other Expenses	1.05M	854.00K	3.70M	0.00	2.70M	0.00	0.00
Operating Expenses	28.19M	11.54M	12.67M	12.56M	16.22M	25.48M	0.00
Cost & Expenses	31.83M	15.10M	16.90M	18.30M	28.69M	26.63M	0.00
Interest Income	0.00	870.00K	344.00K	263.00K	858.00K	282.00K	0.00
Interest Expense	0.00	4.49M	750.00K	3.85M	995.00K	923.00K	0.00
Depreciation & Amortization	-10.34M	1.00M	3.61M	2.01M	2.61M	176.00K	22.82K
EBITDA	-37.75M	-9.04M	-8.40M	-12.52M	-13.71M	-26.06M	0.00
EBITDA Ratio	-854.10%	-178.67%	-171.39%	-226.49%	-447.88%	-23,911.01%	0.00%
Operating Income	-27.41M	-10.04M	-12.00M	-14.53M	-16.33M	-26.24M	0.00
Operating Income Ratio	-620.14%	-198.44%	-244.98%	-262.87%	-533.18%	-24,072.48%	0.00%
Total Other Income/Expenses	13.47M	-3.62M	-702.00K	-3.58M	-137.00K	-923.00K	0.00
Income Before Tax	-13.94M	-14.89M	-12.71M	-16.36M	-17.32M	-27.16M	0.00
Income Before Tax Ratio	-315.43%	-294.40%	-259.31%	-296.11%	-565.68%	-24,919.27%	0.00%
Income Tax Expense	16.00K	-3.00K	-18.00K	-857.00K	-345.00K	85.00K	0.00
Net Income	-13.96M	-14.89M	-12.69M	-15.51M	-16.98M	-27.25M	0.00
Net Income Ratio	-315.79%	-294.35%	-258.94%	-280.60%	-554.41%	-24,997.25%	0.00%
EPS	0.00	-45.89	-60.40	-7.00	-8.60	-20.39	0.00
EPS Diluted	0.00	-45.89	-60.40	-7.00	-8.60	-20.39	0.00
Weighted Avg Shares Out	0.00	324.45K	210.07K	2.21M	1.97M	1.34M	71.11M
Weighted Avg Shares Out (Dil)	0.00	324.45K	210.07K	2.21M	1.97M	1.34M	71.11M

G Medical Innovations Holdings Ltd. Announces a Partnership with Peter N Nielsen to Drive Health and Wellness Innovation

May 20, 2024prnewswire.com

REHOVOT, Israel , May 20, 2024 /PRNewswire/ -- G Medical Innovations Holdings Ltd. (GMVD), a telehealth, medical device, and remote patient monitoring company, announced today a Partnership with Peter N Nielsen to Drive Health and Wellness Innovation.

Why IS G Medical Innovations (GMVD) Stock Up 34% Today?

August 22, 2023investorplace.com

G Medical Innovations (NASDAQ: GMVD ) stock is climbing higher on Tuesday without any clear news from the healthcare company. G Medical Innovations hasn't put out any new press releases that explain why GMVD stock is up today.

G Medical Innovations Will Provide Services to Veterans and Military Personnel by Partnering With Resilient Support Services

August 17, 2023globenewswire.com

Rehovot, Israel, Aug. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations”), an industry innovator in comprehensive remote patient monitoring solutions, today announced that its wholly-owned subsidiary, G Medical Innovations USA, Inc., has entered...

Why Is G Medical Innovations (GMVD) Stock Up 32% Today?

August 15, 2023investorplace.com

G Medical Innovations (NASDAQ: GMVD ) stock is on the rise Tuesday despite a lack of news concerning the mobile health and telemedicine solutions company. There are no new press releases, or filings with the Securities and Exchange Commission (SEC), that...

G Medical Innovations' CEO Issues Update to Shareholders, August 2023

August 7, 2023globenewswire.com

Rehovot, Israel, Aug. 07, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations” or the “Company”), a global leader in next-generation mobile health (mHealth) and digital health, today issued the following update to shareholders from...